First reported case of an OXA-48-producing isolate from a Colombian patient

OXA-48 is a class D b-lactamase that strongly hydrolyses penicillins but has a low level of hydrolytic activity against carbapenems, with much greater activity against imipenem than meropenem.

Autores:
Vanegas, Johanna
Ospina, William
Higuita Gutiérrez, Luis Felipe
Jiménez, J. Natalia
Tipo de recurso:
Article of journal
Fecha de publicación:
2016
Institución:
Universidad Cooperativa de Colombia
Repositorio:
Repositorio UCC
Idioma:
OAI Identifier:
oai:repository.ucc.edu.co:20.500.12494/41912
Acceso en línea:
https://doi.org/10.17533/udea.rfo.v28n2a5
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85021678095&doi=10.3303%2fCET1757010&partnerID=40&md5=8e260266b56c23e9ec06b2518dc46792
https://hdl.handle.net/20.500.12494/41912
Palabra clave:
Rights
closedAccess
License
http://purl.org/coar/access_right/c_14cb
id COOPER2_2f6fa8fb6a38ceb6357c44ce5f6a506a
oai_identifier_str oai:repository.ucc.edu.co:20.500.12494/41912
network_acronym_str COOPER2
network_name_str Repositorio UCC
repository_id_str
spelling Vanegas, JohannaOspina, WilliamHiguita Gutiérrez, Luis FelipeJiménez, J. Natalia2021-12-16T22:15:53Z2021-12-16T22:15:53Z2016https://doi.org/10.17533/udea.rfo.v28n2a5https://www.scopus.com/inward/record.uri?eid=2-s2.0-85021678095&doi=10.3303%2fCET1757010&partnerID=40&md5=8e260266b56c23e9ec06b2518dc4679222137165https://hdl.handle.net/20.500.12494/41912Vanegas J,Ospina W,HIGUITA L,Jime´nez J.N. First reported case of an OXA-48-producing isolate from a Colombian patient. J GLOB ANTIMICROB RE. 2016. 6. (6):p. 67-68. .OXA-48 is a class D b-lactamase that strongly hydrolyses penicillins but has a low level of hydrolytic activity against carbapenems, with much greater activity against imipenem than meropenem.0000-0003-1361-312468-67Elsevier BVFirst reported case of an OXA-48-producing isolate from a Colombian patientArtículohttp://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1http://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articlehttp://purl.org/redcol/resource_type/ARTinfo:eu-repo/semantics/publishedVersionJ GLOB ANTIMICROB REinfo:eu-repo/semantics/closedAccesshttp://purl.org/coar/access_right/c_14cbPublication20.500.12494/41912oai:repository.ucc.edu.co:20.500.12494/419122024-08-20 16:20:02.048metadata.onlyhttps://repository.ucc.edu.coRepositorio Institucional Universidad Cooperativa de Colombiabdigital@metabiblioteca.com
dc.title.spa.fl_str_mv First reported case of an OXA-48-producing isolate from a Colombian patient
title First reported case of an OXA-48-producing isolate from a Colombian patient
spellingShingle First reported case of an OXA-48-producing isolate from a Colombian patient
title_short First reported case of an OXA-48-producing isolate from a Colombian patient
title_full First reported case of an OXA-48-producing isolate from a Colombian patient
title_fullStr First reported case of an OXA-48-producing isolate from a Colombian patient
title_full_unstemmed First reported case of an OXA-48-producing isolate from a Colombian patient
title_sort First reported case of an OXA-48-producing isolate from a Colombian patient
dc.creator.fl_str_mv Vanegas, Johanna
Ospina, William
Higuita Gutiérrez, Luis Felipe
Jiménez, J. Natalia
dc.contributor.author.none.fl_str_mv Vanegas, Johanna
Ospina, William
Higuita Gutiérrez, Luis Felipe
Jiménez, J. Natalia
description OXA-48 is a class D b-lactamase that strongly hydrolyses penicillins but has a low level of hydrolytic activity against carbapenems, with much greater activity against imipenem than meropenem.
publishDate 2016
dc.date.issued.none.fl_str_mv 2016
dc.date.accessioned.none.fl_str_mv 2021-12-16T22:15:53Z
dc.date.available.none.fl_str_mv 2021-12-16T22:15:53Z
dc.type.none.fl_str_mv Artículo
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.coar.none.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.coarversion.none.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.driver.none.fl_str_mv info:eu-repo/semantics/article
dc.type.redcol.none.fl_str_mv http://purl.org/redcol/resource_type/ART
dc.type.version.none.fl_str_mv info:eu-repo/semantics/publishedVersion
format http://purl.org/coar/resource_type/c_6501
status_str publishedVersion
dc.identifier.none.fl_str_mv https://doi.org/10.17533/udea.rfo.v28n2a5
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85021678095&doi=10.3303%2fCET1757010&partnerID=40&md5=8e260266b56c23e9ec06b2518dc46792
dc.identifier.issn.spa.fl_str_mv 22137165
dc.identifier.uri.none.fl_str_mv https://hdl.handle.net/20.500.12494/41912
dc.identifier.bibliographicCitation.spa.fl_str_mv Vanegas J,Ospina W,HIGUITA L,Jime´nez J.N. First reported case of an OXA-48-producing isolate from a Colombian patient. J GLOB ANTIMICROB RE. 2016. 6. (6):p. 67-68. .
url https://doi.org/10.17533/udea.rfo.v28n2a5
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85021678095&doi=10.3303%2fCET1757010&partnerID=40&md5=8e260266b56c23e9ec06b2518dc46792
https://hdl.handle.net/20.500.12494/41912
identifier_str_mv 22137165
Vanegas J,Ospina W,HIGUITA L,Jime´nez J.N. First reported case of an OXA-48-producing isolate from a Colombian patient. J GLOB ANTIMICROB RE. 2016. 6. (6):p. 67-68. .
dc.relation.ispartofjournal.spa.fl_str_mv J GLOB ANTIMICROB RE
dc.rights.accessrights.none.fl_str_mv info:eu-repo/semantics/closedAccess
dc.rights.coar.none.fl_str_mv http://purl.org/coar/access_right/c_14cb
eu_rights_str_mv closedAccess
rights_invalid_str_mv http://purl.org/coar/access_right/c_14cb
dc.format.extent.spa.fl_str_mv 68-67
dc.publisher.spa.fl_str_mv Elsevier BV
institution Universidad Cooperativa de Colombia
repository.name.fl_str_mv Repositorio Institucional Universidad Cooperativa de Colombia
repository.mail.fl_str_mv bdigital@metabiblioteca.com
_version_ 1814247017907486720

Publicaciones similares